BOVE, MARILISA
BOVE, MARILISA
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
BOVE M.; M. BOVE
A comparison study of Lp(a) plasma levels distributions between normo- and hypertensive subjects with high BMI.
2006 Bove M.; Cicero A.F.G.; Derosa G.; Borghi C.; Manca M.; Gaddi A.V.
A nutraceutical based approach to reduce cholesterolemia in patients previously intolerant to more than a statin: a pilot study.
2008 Cicero AFG; Derosa G; Bove M; Grandi E; Uliassi E; Borghi C; Gaddi AV.
Additional therapy for cholesterol lowering in ezetimibe-treated, statin-intolerant patients in clinical practice: results from an internal audit of a university lipid clinic
2016 Cicero, Arrigo F.G; Morbini, Martino; Bove, Marilisa; D’Addato, Sergio; Fogacci, Federica; Rosticci, Martina; Borghi, Claudio
An evidence-based review on urate-lowering treatments: Implications for optimal treatment of chronic hyperuricemia
2017 Bove, Marilisa; Cicero, Arrigo Francesco Giuseppe; Veronesi, Maddalena; Borghi, Claudio
CARDIOVASCULAR DISEASE RISK PERCEPTION IN PATIENTS AFFECTED BY FAMILIAL HYPERLIPIDAEMIAS IN SPECIALIST SETTING
2008 Ghedini, L; Cicero, AF; Manca, M; Bove, M; Borghi, C; Gaddi, AV
Coenzyne Q10 effect on the serum creatinine increase associated to rosuvastatin 20 mg in severe hypercholesterolemic patients
2005 A.F.G., Cicero; G., Derosa; M., Bove; A., Lucicesare; L., Laghi; S., D'Addato; A.Gaddi.
Detection of familial combined hyperlipoproteinaemia patients in the Brisighella Heart Study historical cohort: An epidemiological approach
2007 Cicero, A F G; Manca, M; Bove, M; Dormi, A; Borghi, C; Gaddi, A V; Brisighella Heart Study group.
Different effect of psyllium and guar dietary supplementation on blood pressure control in hypertensive overweight patients: a six-month, randomized clinical trial.
2007 Cicero AF; Derosa G; Manca M; Bove M; Borghi C; Gaddi AV.
Effect of a sequential training program on inflammatory, prothrombotic and vascular remodelling biomarkers in hypertensive overweight patients with or without metabolic syndrome
2009 Cicero AFG; Derosa G; Bove M; Di Gregori V; Gaddi AV; Borghi C.
Effect of Dietary Supplementation with Eufortyn® Colesterolo Plus on Serum Lipids, Endothelial Reactivity, Indexes of Non-Alcoholic Fatty Liver Disease and Systemic Inflammation in Healthy Subjects with Polygenic Hypercholesterolemia: The ANEMONE Study. Nutrients. 2022 May 18;14(10):209
2022 Fogacci F, Rizzoli E, Giovannini M, Bove M, D'Addato S, Borghi C, Cicero AFG
Effect of quantitative and qualitative diet prescription on children behavior after diagnosis of heterozygous familial hypercholesterolemia.
2019 Cicero AFG, Fogacci F, Giovannini M, Bove M, Debellis G, Borghi C.
EFFECT OF QUANTITATIVE AND QUALITATIVE DIET PRESCRIPTION ON CHILDREN BEHAVIOUR AFTER A DIAGNOSIS OF FAMILIAL DYSLIPIDEMIA
2018 Fogacci, F; Cicero, AFG; Bove, M; Rizzoli, E; Esposti, DD; Borghi, C
Effect of Synaid on cognitive functions and mood in elderly subjects with self-perceived loss of memory after COVID-19 infection
2021 Bove M, Fogacci F, Quattrocchi S, Veronesi M, Cicero AFG
Effects of a Combined Nutraceutical on Lipid Pattern, Glucose Metabolism and Inflammatory Parameters in Moderately Hypercholesterolemic Subjects: A Double-blind, Cross-over, Randomized Clinical Trial
2017 Cicero AF, Colletti A, Fogacci F, Bove M, Rosticci M, Borghi C.
Effects of phytosomal curcumin on anthropometric parameters, insulin resistance, cortisolemia and non-alcoholic fatty liver disease indices: a double-blind, placebo-controlled clinical trial
2020 Arrigo F G Cicero , Amirhossein Sahebkar , Federica Fogacci , Marilisa Bove , Marina Giovannini , Claudio Borghi
Effetto di un nutraceutico combinato su sintomi menopausali e fattori di rischio cardiometabolici in donne dislipidemiche affette da sindrome perimenopausale
2017 Cicero, Afg; Bove, M; Fogacci, F; Veronesi, M; Borghi, C
Efficacy and safety of Armolipid Plus®: an updated PRISMA compliant systematic review and meta-analysis of randomized controlled clinical trials.
2021 Cicero AF, Kennedy C, Knežević T, Bove M, Georges CMG, Šatrauskienė A, Toth PP, Fogacci F.
Efficacy of soluble fiber supplementation in CVD risk management of patients affected by metabolic syndrome: A 6-months, open-label, RCT
2007 Laghi, L; Cicero, AFG; Derosa, G; Manca, M; Bove, M; Borghi, C; Gaddi, AV
Emerging drugs for the treatment of hypercholesterolemia
2019 Bove M, Cicero AFG, Borghi C
Estimating the burden of hyperlipidemia in a hypertensive ambulatory population
2006 Cicero A.F.G.; Derosa G.; Bove M.; Laghi L.; Manca M.; Borghi C.; Gaddi A.V.